CLPT - CIK 0001285550
The table below shows ClearPoint Neuro, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.59M | $38.22M | $41.54M | $12.39M | $21.57M | $32.84M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $8.66M | $4.00M | $4.26M | $3.65M | $3.88M | $3.48M |
| Inventory | $8.57M | $6.58M | $6.29M | $6.58M | $7.06M | $8.03M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $54.88M |
| $51.33M |
| $53.99M |
| $24.21M |
| $34.33M |
| $46.56M |
| Property, plant & equipment | $2.91M | $2.11M | $2.02M | $2.18M | $1.70M | $1.54M |
| Goodwill | $7.47M | - | - | - | - | - |
| Total assets | $93.42M | $60.36M | $62.87M | $30.07M | $40.19M | $52.57M |
| Accounts payable | $2.33M | $723.00K | $1.53M | $1.22M | $955.00K | $822.00K |
| Total current liabilities | $9.48M | $8.05M | $7.40M | $6.87M | $7.55M | $16.69M |
| Long-term debt | $49.64M | $29.20M | $28.84M | - | - | $9.98M |
| Total liabilities | $74.58M | $44.48M | $43.13M | $10.08M | $11.19M | $20.44M |
| Retained earnings | -$226.46M | -$209.12M | -$203.23M | -$197.40M | -$185.98M | -$181.01M |
| Total equity | $18.84M | $15.87M | $19.74M | $19.99M | $29.00M | $32.13M |